XPENG Announces Vehicle Delivery Results for May 2026
GUANGZHOU, China, June 1, 2026 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV and HKEX: 9868), a leading global AI mobility technology company, today announced its vehicle delivery results for May 2026. XPENG delivered a total of...
Minghui Pharmaceutical and Qilu Pharmaceutical Co-Announces Updated Clinical Data of MHB088C (QLC5508) from Phase I/II study in Heavily Pretreated mCRPC Patients at 2026 ASCO Annual Meeting
HANGZHOU and SHANGHAI, China, June 1, 2026 /PRNewswire/ -- Minghui Pharmaceutical ("Minghui"), a late-stage clinical biopharmaceutical company focused on developing innovative therapies for oncology and autoimmune diseases, today announced updated...
Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczema
HANGZHOU, China, SHANGHAI and BOSTON, June 1, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that its...
Yozma Announces Landmark Football Partnership for 1st Anniversary
Partnership with the Belgian Red Devils marks a major step in Yozma's global brand evolution. DENVER, May 30, 2026 /PRNewswire/ -- To mark its first anniversary, Yozma has announced a landmark partnership as the North America regional dirt-bike...
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
SHANGHAI, May 29, 2026 /PRNewswire/ -- Zhongchao Inc. ("Zhongchao" or the "Company") (NASDAQ: ZCMD), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced the pricing of a...
Dizal Announces Phase 3 WU-KONG28 Results: ZEGFROVY® (Sunvozertinib) Outperforms Platinum-Doublet Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
ZEGFROVY ® demonstrated superior anti-tumor efficacy compared to platinum-doublet chemotherapy as a first-line treatment for advanced NSCLC with EGFR exon20ins WU-KONG28 is the first global randomized phase 3 study with positive results for an oral,...
RPX Corporation Announces Leadership Transition
Ryan Elliott to Succeed Dan McCurdy as Chief Executive Officer, Effective July 1 SAN FRANCISCO, May 28, 2026 /PRNewswire/ -- RPX Corporation, a leading patent risk management service provider, today announced that Ryan Elliott, industry veteran and...
Cheche Group Inc. Announces Notice of Intent by Founder and CEO Lei Zhang to Purchase Company Shares
BEIJING, May 28, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that its Founder and Chief Executive Officer, Mr. Lei Zhang, has expressed his...
POMDOCTOR LIMITED Announces Plan to Implement ADS Ratio Change
GUANGZHOU, China, May 28, 2026 /PRNewswire/ -- POMDOCTOR LIMITED (the "Company") (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced that it plans to change the ratio of its American Depositary...
Fox ESS Announces Its Rebrand Ahead of SNEC Exhibition, Unveiling A New Brand Journey
WENZHOU, China, May 28, 2026 /PRNewswire/ -- Fox ESS, a global leader in renewable energy solutions, today announced its rebrand, an important step in the brand's ongoing journey of innovation, trust, and long-term commitment to a more resilient...